TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ARA Life Science AB
Closing information (x1000 EUR)
| Closing information | 2023/04 | 2022/04 | 2021/04 |
| Turnover |
15
|
16
|
15 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
13
|
14
|
13 |
| EBITDA |
13
|
14
|
13 |
| Total assets |
26
|
29
|
29 |
| Current assets |
26
|
29
|
29 |
| Current liabilities |
6
|
8
|
8 |
| Equity capital |
20
|
21
|
21 |
| - share capital |
9
|
10
|
10 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Solvency |
76.9%
|
72.4%
|
72.4% |
| Turnover per employee |
8
|
8
|
8 |
| Profit as a percentage of turnover |
86.7%
|
87.5%
|
86.7% |
| Return on assets (ROA) |
50.0%
|
48.3%
|
44.8% |
| Current ratio |
433.3%
|
362.5%
|
362.5% |
| Return on equity (ROE) |
65.0%
|
66.7%
|
61.9% |
| Change turnover |
0
|
1
|
1 |
| Change turnover % |
3%
|
9%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.